SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-20-000039
Filing Date
2020-11-09
Accepted
2020-11-09 16:01:56
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20200930.htm   iXBRL 10-Q 1328689
2 EX-31.1 ex-311q32020.htm EX-31.1 8948
3 EX-31.2 ex-312q32020.htm EX-31.2 9494
4 EX-32.1 ex-321q32020.htm EX-32.1 4326
5 EX-32.2 ex-322q32020.htm EX-32.2 4369
  Complete submission text file 0001113148-20-000039.txt   5328131

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20200930.xsd EX-101.SCH 52405
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20200930_cal.xml EX-101.CAL 80709
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20200930_def.xml EX-101.DEF 192055
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20200930_lab.xml EX-101.LAB 507715
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20200930_pre.xml EX-101.PRE 300499
11 EXTRACTED XBRL INSTANCE DOCUMENT infi-20200930_htm.xml XML 719291
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 201297624
SIC: 2834 Pharmaceutical Preparations